Preferential Treatment: Historically, most medical research and clinical trials have been conducted on able-bodied, cisgender, white men. This exposes others, particularly disabled women or women suffering from chronic health conditions, to biases, poorer health outcomes, and without recourse against potentially invasive medical treatment. How can the EU encourage the development of a more inclusive and comprehensive healthcare research practice and ensure equitable treatment for all people?